Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 659755Generated: October 26, 2026

Triethylamine hydrochloride → Irbesartan

https://huagongshe.com/reaction/659755

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamine hydrochlorideHCID 11130—
ReactantSodium HydroxideHCID 14798—
ReactantSodium AzideHCID 33557—
Reactant4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
ProductIrbesartanHCID 374995%

Reaction Steps

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and triethylamine hydrochloride (7.1 g) in N,N-dimethylformamide (30 ml) was refluxed for 14 hours under stirring. The reaction was cooled to room temperature and 20 ml water was added. The reaction mixture was adjusted to pH of about 12 using 10% NaOH solution. The alkaline solution was washed with toluene (15 ml) and the aqueous phase was neutralized to pH of 6.5 using concentrated HCl. The resulting suspension was stirred for 3 hours at room temperature and filtered to obtain irbesartan (3.4 g, 95% purity by HPLC). Recrystallization of the product using ethanol results in 3.05 g of irbesartan with 99.2% purity and content of the impurity 2-n-butyl-3-[(2′-carboxamidobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one: 0.09%.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08080670B2
Source datasetuspto-grants-2011_12
ORD IDord-88d06e44cbbc4a08b80e3b57e331ef71
Source noteuspto-grants-2011_12